metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the FDA-authorized, gut-directed hypnotherapy Regulora, including an openness to outcomes-based pricing and the wider go-to-market strategy. READ
CHICAGO, December 9, 2022 – metaMe Health breaks into the top 150 of the most promising private digital health companies of 2022. By being recognized in CB Insights prestigious “Digital Health 150” list, metaMe Health is recognized by industry leaders worldwide for their achievements in pioneering
metaMe Health licenses rights to commercialization of Regulora in Canada to Launchit Ventures, Inc. to expedite the availability of Regulora to Irritable Bowel Syndrome (IBS) patients. Hamilton, ON, Canada and Chicago, IL, United States, September 29, 2022 – Launchit Ventures, Inc., a HealthTec
Agreement with Dr. Sarah Kinsinger and Dr. Olafur Palsson gives metaMe Health global rights to develop and market the digital therapeutic Functional dyspepsia, a chronic disorder of the upper gastrointestinal tract, is estimated to affect 10-20% of people who seek health care for indigestion sy
metaMe Health offers prescription digital therapeutics (PDTs), software applications prescribed to train the brain to help manage chronic conditions. They are used on smartphones or tablets.
